<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02494648</url>
  </required_header>
  <id_info>
    <org_study_id>1408189</org_study_id>
    <secondary_id>2015-A00030-49</secondary_id>
    <nct_id>NCT02494648</nct_id>
  </id_info>
  <brief_title>Effects of Inspiratory Muscles Strengthening Among Coronary Patients on the Sleep Apnea Obstructive Syndrome</brief_title>
  <acronym>RICAOS</acronym>
  <official_title>Effects of Inspiratory Muscles Strengthening Among Coronary Patients on the Sleep Apnea Obstructive Syndrome (SAOS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstructive sleep apnea (OSA) syndrome affects up to 5% of the general population. The
      prevalence is multiplied by 13 in coronary artery disease (CAD) patients. Many studies have
      shown that OSA syndrome was the main risk factor for cardiovascular morbidity and mortality
      (RR = 9.1 [95%, 2.6 to 31.2]).

      If the value of treatment with Continuous Positive Airway Pressure (CPAP) in symptomatic CAD
      patients (daytime sleepiness and/or 2 clinical symptoms with Apnea Hypopnea Index (AHI) ≥ 20)
      appears to be established, treatment with CPAP in asymptomatic CAD patients (with AHI&gt; 30)
      may be too demanding. Alternative treatments are rare and results are highly variable.
      Therefore, it would be interesting to suggest other treatment modalities with moderate
      coronary and/or minimally symptomatic OSA syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to assess the relevance of inspiratory muscles strengthening on reducing AHI
      in CAD patients with moderate OSA (AHI between 15 and 30).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2015</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AHI Variation</measure>
    <time_frame>At 6 weeks</time_frame>
    <description>It is the difference between the AHI at the inclusion et the AHI at 6 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Circumference of the neck in centimetre</measure>
    <time_frame>At 6 weeks</time_frame>
    <description>in centimetre</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epworth questionnaire to evaluate the deficit of sleep</measure>
    <time_frame>at 6 weeks</time_frame>
    <description>This questionnaire evaluates the deficit of sleep</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh questionnaire to evaluate the quality of sleep</measure>
    <time_frame>At 6 weeks</time_frame>
    <description>This questionnaire evaluates the quality of sleep</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF12 questionnaire to evaluate the quality of life</measure>
    <time_frame>At 6 weeks</time_frame>
    <description>This questionnaire evaluates the quality of life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Inspiratory muscles strengthening</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The device used is : POWERbreathe Fitness Plus, (POWERbreathe International Ltd, UK).
Class I, CE labelled. POWERbreathe fitness Plus uses the technique of training against resistance to increase the strength, the power and the endurance of the respiratory muscles (diaphragm and rib cage).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>POWERbreathe Fitness Plus, (POWERbreathe International Ltd, UK) [Inspiratory muscles strengthening]</intervention_name>
    <description>CAD patients participated in a 6-week (20 sessions of training) resistive inspiratory muscle training (RIMT) program for 10 minutes twice daily at a training intensity of 70% of maximum inspiratory pressure (MIP).</description>
    <arm_group_label>Inspiratory muscles strengthening</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with moderate OSA (15 &lt;AHI &lt;30)

          -  Period between acute coronary syndrome and inclusion &lt;60 days

          -  Patients included in cardiac rehabilitation

        Exclusion Criteria:

          -  Obstructive lung disease with Tiffeneau index less than 70%.

          -  Restrictive lung disease with a reduction of total lung capacity (TLC)

          -  Treatment for OSA or clinical context (comorbidity) justifying CPAP

          -  Congestive heart failure, thoracic surgery by sternotomy

          -  Spontaneous pneumothorax

          -  Severe Asthma

          -  Ruptured eardrum, or another disease of the middle ear, or acute sinusitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David HUPIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint-Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David HUPIN, MD</last_name>
    <phone>(0)477829109</phone>
    <phone_ext>+33</phone_ext>
    <email>david.hupin@chu-st-etienne.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Saint-Etienne</name>
      <address>
        <city>Saint-etienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David HUPIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédéric ROCHE, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédéric COSTES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Claude BARTHELEMY, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2015</study_first_submitted>
  <study_first_submitted_qc>July 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2015</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obstructive sleep apnea</keyword>
  <keyword>Resistive inspiratory muscle training</keyword>
  <keyword>Coronary artery disease</keyword>
  <keyword>Cardiac rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

